Compare Gigacloud Technology Inc (GCT) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Gigacloud Technology Inc trades at $57.21 (market cap $2.02B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 3× Gigacloud Technology Inc's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 1,020,985). Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 21 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| GCT | IOVA | |
|---|---|---|
Market Cap | $2.02B | $6.04B |
Volume | 1,020,985 | 14,805,993 |
Sector | Technology | Health |
52-Week High | $56.42 | $14.82 |
52-Week Low | $25.46 | $1.81 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $2.14B | $5.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $57.26, up 2.32% today, with a bullish technical outlook and strong earnings momentum after beating EPS estimates for three consecutive quarters. The stock shows robust profitability with a 10.65% net income margin and 32.34% ROE, supported by positive cash flow from operations of $190.66 million in 2025. Recent news highlights institutional interest and expansion into European markets.
The outlook is positive with revenue growth to $1.5 billion projected for 2026 and a consensus analyst price target of $32.50, though risks include insider selling and competitive pressures in the consumer discretionary sector. The stock's current price near resistance at $58 suggests potential for volatility amid overbought short-term conditions.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
